Phase 1/2 trial of anti-CD7 allogeneic WU-CART-007 for patients with relapsed/refractory T-cell malignancies
抗CD7同种异体WU-CART-007治疗复发/难治性T细胞恶性肿瘤患者的1/2期临床试验
期刊:Blood
影响因子:23.1
doi:10.1182/blood.2025028387
Ghobadi, Armin; Aldoss, Ibrahim; Maude, Shannon L; Bhojwani, Deepa; Wayne, Alan S; Bajel, Ashish; Dholaria, Bhagirathbhai; Faramand, Rawan; Mattison, Ryan J; Rijneveld, Anita; Zwaan, C Michel; Calkoen, Friso; Baruchel, Andre; Boissel, Nicolas; Rettig, Michael; Wood, Brent; Jacobs, Kenneth; Christ, Stephanie; Irons, Haley; Capoccia, Ben; Masters, Deborah; Gonzalez, Justo; Wu, Tony; Rosario, Maria Del; Hamil, Alexander; Bakkacha, Ouiam; Muth, John; Ramsey, Brett; McNulty, Eileen; Baughman, Jan; Cooper, Matthew L; Davidson-Moncada, Jan; DiPersio, John F
CD7
免疫/内分泌
细胞生物学
T细胞
肿瘤
肿瘤免疫
T细胞